Results 31 to 40 of about 697,104 (329)
Toxins, 2014 Anthrax Vaccine Adsorbed (AVA) generates short-lived protective antigen (PA) specific IgG that correlates with in vitro toxin neutralization and protection from Bacillus anthracis challenge.
Lori Garman +5 more
doaj +1 more source
Computational modeling of TC0583 as a putative component of the Chlamydia muridarum V-type ATP synthase complex and assessment of its protective capabilities as a vaccine antigen. [PDF]
, 2016 Numerous Chlamydia trachomatis proteins have been identified as potential subunit vaccines, of which the major outer-membrane protein (MOMP) has, so far, proven the most efficacious. Recently, subunit A of the V-type ATP synthase (ATPase; TC0582) complex
Barta, Michael L +4 more
core +1 more source
Changes in Biomodels in Response to Recombinant Protective Anthrax Antigen Inoculation
Проблемы особо опасных инфекций, 2013 one. The data obtained has substantiated the lack of an expressed damaging effect of the recombinant protective antigen on the cells and tissues of the macroorganism, as well as possibility of its application as one of the core components of the ...
P. Yu. Popova +5 more
doaj +1 more source
Vaccines Against Anthrax – Selected Research
Postępy Mikrobiologii, 2022 New strategies in the development of anthrax vaccines and therapeutics have been presented. Recently, considerable progress has been made in the finding of new drugs and suitable therapy for anthrax.
Żakowska Dorota +4 more
doaj +1 more source
Recombinant expression systems: the obstacle to helminth vaccines? [PDF]
, 2007 A
Claerebout, Edwin +3 more
core +2 more sources
Проблемы особо опасных инфекций, 2012 Assessment of immunogenicity and biological safety of protective antigen preparation obtained from asporogenic recombinant producer, B. anthracis 55ΔTPA-1(Spo-), is made on the mice (BALB/c species) and Guiney pigs models.
P. Yu. Popova +9 more
doaj +1 more source
Salmonella Vaccines: Conduits for Protective Antigens [PDF]
The Journal of Immunology, 2018 Abstract Vaccines afford a better and more cost-effective approach to combatting infectious diseases than continued reliance on antibiotics or antiviral or antiparasite drugs in the current era of increasing incidences of diseases caused by drug-resistant pathogens.
Josephine E, Clark-Curtiss, Roy, Curtiss
openaire +2 more sources
Toxins, 2013 Inhaled Bacillus anthracis spores germinate and the subsequent vegetative growth results in bacteremia and toxin production. Anthrax toxin is tripartite: the lethal factor and edema factor are enzymatic moieties, while the protective antigen (PA) binds ...
Cecil Chen +6 more
doaj +1 more source
Use of recombinant virus replicon particles for vaccination against Mycobacterium ulcerans disease [PDF]
, 2015 Buruli ulcer, caused by infection with Mycobacterium ulcerans, is a necrotizing disease of the skin and subcutaneous tissue, which is most prevalent in rural regions of West African countries.
Bolz, Miriam +3 more
core +3 more sources
Инфекция и иммунитет, 2019 Currently, live anthrax vaccine has been used for vaccine prophylaxis in Russia and neighbor countries for seve ral decades, but precise mechanism of post-vaccination protection mechanism remains unclear. Here, we provide data on examining serum antibody
V. V. Firstova +6 more
doaj +1 more source